SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001835567-22-000037
Filing Date
2022-05-16
Accepted
2022-05-16 17:19:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 2022 10-Q pear424b32022q110-qcombined.htm 424B3 1130787
2 EX-31.1 CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) exhibit311certificationcmc.htm EX-31.1 10430
3 EX-31.2 CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) exhibit312certificationcgu.htm EX-31.2 10511
4 EX-32.1 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 exhibit32jointcertificatio.htm EX-32.1 5808
5 image_0a.jpg GRAPHIC 233457
6 logo-pearxtherapeuticsxfina.jpg GRAPHIC 650556
  Complete submission text file 0001835567-22-000037.txt   2371886
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261876 | Film No.: 22931013
SIC: 8000 Services-Health Services